Clinical Trial

AGECTO Study: PCI vs. Optimal Medical Therapy for CTO in the Octogenarian Patients

Study acronym: AGECTO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study compares an interventional strategy (PCI) with optimal medical therapy (OMT) in ultra-octogenarians with chronic total occlusions (CTO). Results suggest that successful PCI leads to significant improvements in symptoms and quality of life compared to OMT alone. While initially carrying higher procedural risks, CTO-PCI is considered feasible and safe in experienced centers. There is also potential for long-term benefits in survival and a reduction in major adverse cardiovascular events (MACE). The choice between treatments depends on an individual risk-benefit assessment, considering the patient's overall condition.
Trial Details
NCT Number NCT07442526
Lead Sponsor San Luigi Gonzaga Hospital
Conditions Coronary Artery Disease (CAD), Chronic Total Occlusion (CTO), Percutaneous Coronary Intervention (PCI), Optimal Medical Therapy
Enrollment 200 participants
Start Date 2025-07-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-02